301 Biologic Drugs for the Management of Axial Spondyloarthritis
- Year:2019
- Document Type:Clinical Commissioning Policy
- Clinical Support area:
- Musculoskeletal (MSK)
- Rheumatology
- Clinical Service area:Rheumatology
- Synonyms:
- spondyloarthritis
- Biologic
- biosimilar
- secukinumab
- Adalimumab
- etanercept
- certolizumab
- golimumab
- infliximab
- Secondary Care